This Startup Wants To Use Mini Robots To Treat Alzheimer’s

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

Iranian Hackers Are Using Elon Musk’s Starlink To Stay Online

As the attacks continue, Iranians have turned to Space X’s satellite internet technology — including one of the country’s most notorious hacker crews, which is claiming retaliatory cyberattacks against the U.S.

Data Center Batteries Enter The Iron Age

This week’s Current Climate newsletter also looks at how Red Texas is turning green when it comes to energy and building up U.S. supply chains for a better electric grid

Google’s Data Center Buildout Could Top $1 Trillion

In an exclusive interview, Google’s new AI infrastructure chief says the tech giant has a “significant investment” planned. At current levels, Forbes projects it could be a very big number indeed.

Jesse Jackson’s Early HIV/AIDS Advocacy Transformed The Course Of The Disease

Jackson’s advocacy caused a shift in both behavior and attitudes toward HIV/AIDS. He helped chart a course of action that led to improved prevention and treatments.

Warning: AI Is Coming For Your 401(k)

Stocks have low earnings yields and TIPS have good yields. Move money from stocks into bonds.

Malaysian Billionaire Jeffrey Cheah’s Sunway Healthcare To Raise $736 Million From IPO

Sunway Healthcare—controlled by Malaysian billionaire Jeffrey Cheah’s Sunway Group—will use proceeds from the IPO to partly finance expansion plans, which include building three new hospitals.

The Startup Building An Operating System For Biotech AI

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in this week’s edition of The Prototype.

This Looming Drug Development Gap Could Impact Patients’ Health

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Novo Nordisk Inks A $2.1 Billion Deal To Develop Next Generation Obesity Pills

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.